The United States is India’s largest market for medicines, particularly affordable generics. In 2024, India exported $3.6 billion (₹31,626 crore) worth of pharmaceutical products to the US, followed by $3.7 billion (₹32,505 crore) in just the first half of 2025.

Bitter Pill for Indian drugmakers: Trump’s 100% drug tariff could give India a headache worth BILLIONS. Here's how

Former U.S. President Donald Trump is now pushing for a trade reset with India, calling Prime Minister Narendra Modi a “very good friend”: a sharp contrast to his earlier rhetoric calling India a “dead economy” and slapping 50% tariffs on Indian imports. As both leaders express optimism about renewed negotiations, unresolved tensions remain, from India’s energy ties with Russia to past trade disputes. Is this a genuine reset or a strategic pivot as U.S. elections loom? This episode breaks down the diplomatic shift, the political motivations behind it, and what it means for India–U.S. relations going forward.


Can US-India trade relations really improve? | Trump courts Modi on trade

india-us-trade-ties

India Us Trade Ties, News on India Us Trade Ties, stories on India Us Trade Ties, articles on India Us Trade Ties, India Us Trade Ties stories at Wion, India Us Trade Ties news, India Us Trade Ties latest news

india us-trade-ties

Bitter Pill for Indian drugmakers: Trump’s 100% drug tariff could give India a headache worth BILLIONS. Here's how

Can US-India trade relations really improve? | Trump courts Modi on trade